194 related articles for article (PubMed ID: 33361676)
1. Fabry Disease on Peritoneal Dialysis with Cardiac Involvement.
Koga-Kobori S; Sawa N; Kido R; Sekine A; Mizuno H; Yamanouchi M; Hayami N; Suwabe T; Hoshino J; Kinowaki K; Ohashi K; Fujii T; Ubara Y
Intern Med; 2021 May; 60(10):1561-1565. PubMed ID: 33361676
[TBL] [Abstract][Full Text] [Related]
2. Late-onset Fabry disease: the cardiac sequela.
Tremblay J; Kim S; Philbin E; Beers K; Lightle A; Belov D
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35680278
[TBL] [Abstract][Full Text] [Related]
3. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.
Chimenti C; Pieroni M; Morgante E; Antuzzi D; Russo A; Russo MA; Maseri A; Frustaci A
Circulation; 2004 Aug; 110(9):1047-53. PubMed ID: 15313943
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in Turkish population (LVH-TR).
Kis M; Dogan Y; Yildirim A; Güzel T; Bekar L; Akhan O; Dogdus M; Harbalıoğlu H; Karabulut D; Soydan E; Zoghi M; Ergene O;
Acta Cardiol; 2022 Nov; 77(9):836-845. PubMed ID: 36222672
[TBL] [Abstract][Full Text] [Related]
6. [Isolated left ventricular hypertrophy : is it a Fabry disease?].
Barbey F; Dormond O; Monzambani V; Barbey G; Namdar M; Monney P
Rev Med Suisse; 2020 Oct; 16(709):1886-1890. PubMed ID: 33026733
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Cerebrovascular Complications under Enzyme Replacement Therapy in a Patient with Fabry Disease on Peritoneal Dialysis.
Muto R; Suzuki Y; Shimizu H; Yasuda K; Ishimoto T; Maruyama S; Ito Y; Mizuno M
Intern Med; 2023 Feb; 62(4):565-569. PubMed ID: 35831104
[TBL] [Abstract][Full Text] [Related]
8. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy.
Kim WS; Kim HS; Shin J; Park JC; Yoo HW; Takenaka T; Tei C
J Korean Med Sci; 2019 Feb; 34(7):e63. PubMed ID: 30804731
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.
Pisani A; Spinelli L; Sabbatini M; Andreucci MV; Procaccini D; Abbaterusso C; Pasquali S; Savoldi S; Comotti C; Cianciaruso B
Am J Kidney Dis; 2005 Jul; 46(1):120-7. PubMed ID: 15983965
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
Talbot AS; Lewis NT; Nicholls KM
Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
[TBL] [Abstract][Full Text] [Related]
12. A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients.
Kubo T; Amano M; Takashio S; Okumura T; Yamamoto S; Nabeta T; Oikawa M; Kurisu S; Ochi Y; Sugiura K; Baba Y; Kuroiwa H; Hirota T; Yamasaki N; Ishii S; Nochioka K; Takeishi Y; Yasuda S; Tsujita K; Izumi C; Kitaoka H
J Cardiol; 2022 Oct; 80(4):325-331. PubMed ID: 35643740
[TBL] [Abstract][Full Text] [Related]
13. Persistent increase in cardiac troponin I in Fabry disease: a case report.
Tanislav C; Feustel A; Franzen W; Wüsten O; Schneider C; Reichenberger F; Rolfs A; Sieweke N
BMC Cardiovasc Disord; 2011 Jan; 11():6. PubMed ID: 21281467
[TBL] [Abstract][Full Text] [Related]
14. Autopsy Findings of Heterozygous Fabry Disease with the Severe Phenotype: A Case Report.
Hiratsuka M; Koyama K; Ito M; Sato R; Suzuki K; Ito Y; Namba-Hamano T; Hamano T
Nephron; 2022; 146(2):203-208. PubMed ID: 34808632
[TBL] [Abstract][Full Text] [Related]
15. Application of Genetic Testing in Unveiling the Diagnosis of Fabry Disease in a Patient with Hypertrophic Cardiomyopathy.
Gedela M; Sharma R; DeBerg K; Stanton C
S D Med; 2021 Apr; 74(4):150-152. PubMed ID: 34432960
[TBL] [Abstract][Full Text] [Related]
16. Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation.
Hsu TR; Hung SC; Chang FP; Yu WC; Sung SH; Hsu CL; Dzhagalov I; Yang CF; Chu TH; Lee HJ; Lu YH; Chang SK; Liao HC; Lin HY; Liao TC; Lee PC; Li HY; Yang AH; Ho HC; Chiang CC; Lin CY; Desnick RJ; Niu DM
J Am Coll Cardiol; 2016 Dec; 68(23):2554-2563. PubMed ID: 27931613
[TBL] [Abstract][Full Text] [Related]
17. Concurrent fabry disease and immunoglobulin a nephropathy: a case report.
Zhou LN; Dong SS; Zhang SZ; Huang LW; Huang W
BMC Nephrol; 2023 Nov; 24(1):324. PubMed ID: 37914990
[TBL] [Abstract][Full Text] [Related]
18. The beneficial effects of long-term enzyme replacement therapy on cardiac involvement in Japanese Fabry patients.
Hongo K; Ito K; Date T; Anan I; Inoue Y; Morimoto S; Ogawa K; Kawai M; Kobayashi H; Kobayashi M; Ida H; Ohashi T; Taniguchi I; Yoshimura M; Eto Y
Mol Genet Metab; 2018 Jun; 124(2):143-151. PubMed ID: 29747997
[TBL] [Abstract][Full Text] [Related]
19. Fabry's disease presenting as ventricular tachycardia and left ventricular 'hypertrophy'.
Joshi SB; Ahmar W; Lee G; Aggarwal A
Eur J Echocardiogr; 2008 Sep; 9(5):697-9. PubMed ID: 18490300
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS).
Palecek T; Honzikova J; Poupetova H; Vlaskova H; Kuchynka P; Golan L; Magage S; Linhart A
J Inherit Metab Dis; 2014 May; 37(3):455-60. PubMed ID: 24173410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
